Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia. [electronic resource]
- Blood advances 04 2020
- 1518-1525 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2473-9537
10.1182/bloodadvances.2019000874 doi
Adult Antibodies, Bispecific--therapeutic use Antineoplastic Agents--therapeutic use Consolidation Chemotherapy Humans Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy